Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic

Keyphrases

• Bone Mineral Density 100%
• Pharmacist 100%
• Teriparatide 100%
• T-score 100%
• Spine 50%
• Total Hip 50%
• Osteoporosis 33%
• Wrist 33%
• Adverse Events 16%
• Endocrinology 16%
• Antiresorptive 16%
• Primary Outcome Measure 16%
• Prospective Observational Study 16%
• Absorptiometry 16%
• Fracture Events 16%
• Decreased Bone Density 16%
• Endocrinologist 16%
• Total Spinal 16%
• Wrist Bone 16%
• New Fracture 16%
• Counselling Session 16%
• Training Session 16%
• Hip-spine 16%
• Therapeutic Design 16%
• Total Wrist 16%
• Private Practice 16%
• Clinical Pharmacist 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Parathyroid hormone[1-34] 100%
• Adverse Event 20%
• Observational Study 20%